European Companies Search Engine

EU funding (€5,199,814): Breakthrough Regulatory Innovation and Development throuGh sandbox Environments Hor1 Nov 2025 EU Research and Innovation programme "Horizon"

Overview

Text

Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

BRIDGE aims to enhance healthcare innovation in Europe by developing a comprehensive framework for designing and operationalizing regulatory sandboxes. By addressing current regulatory limitations and engaging all stakeholders while ensuring compliance, the project seeks to create adaptable, fit-for-purpose methodologies that strengthen the regulatory ecosystem's capacity to promote healthcare innovation. The project’s objectives include identifying and analysing existing regulatory sandboxes across various domains and maturity levels, to determine how their modules can complement current healthcare regulations. BRIDGE will develop a horizon scanning methodology to continuously identify emerging technologies that challenge existing regulatory systems, analyzing their requirements for potential inclusion in regulatory sandboxes to ensure adaptability within an evolving innovation ecosystem. Through multi-stakeholder consultations, BRIDGE will elaborate and assess case studies, as well as develop operational checklists for module design and evidence packages to guide tailored sandbox launches. The project will also develop the Modular Operational Sandbox for Healthcare Innovation and Compliance (MOSAIC), an architectural model with interconnected modules featuring detailed functional specifications and mapped information flows aligned with specific case studies. Additionally, BRIDGE will engage key stakeholders—including regulatory bodies, industry consortia, HTA bodies, payers, healthcare providers, and patients—in an in-depth analysis, consultation, and consensus-building process to ensure the sandbox approach is comprehensive, functional, and adaptable to future advancements. Finally, the project will deliver comprehensive recommendations for the sandbox methodology’s end-to-end operations, encompassing legal, compliance, policy, and regulatory outputs to provide a robust implementation framework.


Funded Companies:

Company name Funding amount
Eli Lilly and Company Ltd. ?
ACADEMISCH ZIEKENHUIS GRONINGEN €229,894
ASTELLAS PHARMA EUROPE B.V. €0.00
Biogen Idec Ltd. €0.00
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE €402,613
CHARITE - UNIVERSITAETSMEDIZIN BERLIN €228,123
CSL BEHRING GmbH €0.00
ELI LILLY AND COMPANY €0.00
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG mbH €794,100
EUROSCAN INTERNATIONAL NETWORK e. V. €473,940
F. HOFFMANN-LA ROCHE AG €0.00
Federation Europeenne d'Associations et d'Industries Pharmaceutiques €0.00
Fundacion Publica Andaluza Progreso y Salud M.P €270,313
Janssen Pharmaceutica N.V. €0.00
MERCK KGaA €0.00
MERCK SHARP & DOHME Corp. €0.00
NOVARTIS PHARMA AG €0.00
Novo Nordisk A/S €0.00
PFIZER Inc. €0.00
Sanofi-Aventis Recherche & Developpement €0.00
TAKEDA PHARMACEUTICALS INTERNATIONAL AG €0.00
TECHNISCHE UNIVERSITAET DRESDEN €132,103
TEKNOLOGIAN TUTKIMUSKESKUS VTT Oy €519,007
TEVA PHARMACEUTICAL INDUSTRIES Ltd. €0.00
THE European Association Medical Devices-Notified Bodies €110,625
THE European Institute for Innovation Through Health Data €584,063
THE EUROPEAN MEDICINES AGENCY €197,595
Universite Bourgogne Europe €159,669
Vlaamse Instelling Voor Technologisch Onderzoek N.V. €1,097,773

Source: https://cordis.europa.eu/project/id/101219311

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Lilly Industries Ltd., Basingstoke.

Creative Commons License The visualizations for "Eli Lilly and Company Ltd. - EU funding (€5,199,814): Breakthrough Regulatory Innovation and Development throuGh sandbox Environments" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.